Test Code PBLI Plasma Cell Assessment, Blood
Reporting Name
Plasma Cell Assessment, BPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Detecting peripheral blood involvement by plasma cell proliferative disorders
Establishing the diagnosis of and determining prognosis for plasma cell proliferative disorders
Method Name
Flow Cytometry
Shipping Instructions
Specimen must arrive within 3 days of collection.
Necessary Information
Date and time of collection are required.
Specimen Required
Container/Tube:
Preferred: Green top (sodium heparin)
Acceptable: Lavender top (EDTA)
Specimen Volume: 10 mL
Collection Instructions:
1. Do not centrifuge.
2. Send whole blood specimen in original tube. Do not aliquot.
Specimen Type
Whole bloodSpecimen Minimum Volume
4 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Whole blood | Ambient (preferred) | 72 hours | |
Refrigerated | 72 hours |
Reject Due To
Gross hemolysis | Reject |
Reference Values
An interpretive report will be provided.
Interpretation
In normal peripheral blood specimens, no clonal plasma cells are present (polytypic or too few to detect).
Plasma cells are CD38 and CD138 positive.
Normal (polyclonal, nonneoplastic) plasma cells are typically CD19-positive, whereas neoplastic (clonal) plasma cells typically are CD19-negative. CD19 expression is especially helpful in distinguishing clonal from nonclonal plasma cells when few analyzable cells are present.
CD45 may be expressed by both normal and neoplastic plasma cells. In some plasma cell proliferative disorders, there are both CD45-positive and CD45-negative subsets within the clonal cell population.
The evaluation of these antigens aids in the identification of abnormal plasma cells; however, they will not be reported independently.
Day(s) Performed
Monday through Saturday
Report Available
1 to 2 daysTest Classification
This test was developed using an analyte specific reagent. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
88184-Flow cytometry, cell surface, cytoplasmic
88185 x 5-Each additional marker
88187-Flow cytometry, interpretation; 2 to 8 markers
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
PBLI | Plasma Cell Assessment, B | 86900-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
30388 | Blood Plasma Cell Light Chain | 86900-8 |
26838 | # Monotypic PCs per 150,000 events | 19099-1 |
26839 | PC Event Interpretation | 69052-9 |
Forms
If not ordering electronically, complete, print, and send a Hematopathology/Cytogenetics Test Request (T726) with the specimen.
Testing Algorithm
The following algorithms are available: